He is focused on developing immunomodulatory peptides at the National Polytechnic Institute in Mexico City. He earned his Master's and Doctorate degrees in Pharmacology at CINVESTAV, during which he specialized in the physicochemical and biological characterization of peptides, therapeutic proteins, and complex drugs. He has experience in establishing orthogonal characterization analyses, defining quality control attributes, and conducting safety, efficacy, developability, pharmacokinetic, and biodistribution assays for bioactive peptides and proteins at preclinical levels and for first-in-human assays. He has participated in bioequivalence studies and biocomparability assays under a quality management system and in accordance with International pharmaceutical regulatory guidelines. His scientific contribution consists of 34 articles in internationally peer-reviewed journals, accounting for an H-index of 12. He also has a patent application as an inventor for immunomodulatory peptides.
His work has allowed him to contribute to the development of high-quality human capital at both the undergraduate and graduate levels. He is a member of the National System of Researchers of Mexico, the National College of Pharmaceutical Chemists and Biologists, the Mexican Society of Immunology, and the American Peptide Society. He also collaborates with Mexico's Federal Commission for Protection against Sanitary Risks (COFEPRIS) on the adaptation of national regulatory guidelines.
He is focused on developing immunomodulatory peptides at the National Polytechnic Institute in Mexico City. He earned his Master's and Doctorate degrees in Pharmacology at CINVESTAV, during which he specialized in the physicochemical and biological characterization of peptides, therapeutic proteins, and complex drugs. He has experience in establishing orthogonal characterization analyses, defining quality control attributes, and conducting safety, efficacy, developability, pharmacokinetic, and biodistribution assays for bioactive peptides and proteins at preclinical levels and for first-in-human assays. He has participated in bioequivalence studies and biocomparability assays under a quality management system and in accordance with International pharmaceutical regulatory guidelines. His scientific contribution consists of 34 articles in internationally peer-reviewed journals, accounting for an H-index of 12. He also has a patent application as an inventor for immunomodulatory peptides.
His work has allowed him to contribute to the development of high-quality human capital at both the undergraduate and graduate levels. He is a member of the National System of Researchers of Mexico, the National College of Pharmaceutical Chemists and Biologists, the Mexican Society of Immunology, and the American Peptide Society. He also collaborates with Mexico's Federal Commission for Protection against Sanitary Risks (COFEPRIS) on the adaptation of national regulatory guidelines.